Nicotine, as a novel tolerogenic adjuvant, enhances the efficacy of immunotherapy in a mouse model of allergic asthma
Sign Up to like & getrecommendations! Published in 2019 at "Research in Pharmaceutical Sciences"
DOI: 10.4103/1735-5362.263555
Abstract: An increasing trend in the incidence of allergic diseases including asthma and related morbidity and mortality is observed worldwide during the last decades. Allergen-specific immunotherapy is suggested for the treatment of some allergic diseases; nevertheless,… read more here.
Keywords: tolerogenic adjuvant; mouse model; allergic asthma; model allergic ... See more keywords